Skip to content

Amgen Inc.

AMGN

CIK 0000318154

← back to feed
Revenue (TTM)
$35.5B
+10.0% YoY Q1 Apr 2026
Net Income (TTM)
$8.2B
+88.5% YoY Q1 Apr 2026
EPS Diluted (TTM)
$15.12
+88.2% YoY Q1 Apr 2026
Gross Margin
13.3%
Q1 Apr 2026
Operating Margin
25.4%
Q1 Apr 2026
Net Margin
23.1%
Q1 Apr 2026
Free Cash Flow (TTM)
$3.64B
Q1 Apr 2026
Cash
$12.04B
Q1 Apr 2026
Total Debt
$53.89B
Q1 Apr 2026
Shares Outstanding
539.71M sh
Q1 Apr 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings